An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
In this study, we report the management, in Lombardy, Italy, of one patient with Cushing's syndrome due to adrenal adenoma and another one with pheochromocytoma, whose surgeries were deferred owing to the COVID-19 pandemic.
The authors declare that they have no conflicts of interest.
References
Nieman L. K., Biller B. M. K., Findling J. W., et al. Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline practice guideline. Journal of Clinical Endocrinology & Metabolism . 2015;100(8):2807–2831. doi: 10.1210/jc.2015-1818.
-
DOI
-
PMC
-
PubMed
Lenders J. W. M., Duh Q.-Y., Eisenhofer G., et al. Endocrine Society. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism . 2014;99(6):1915–1942. doi: 10.1210/jc.2014-1498.
-
DOI
-
PubMed
Newell-Price J., Nieman L. K., Reincke M., Tabarin A. Endocrinology in the time of COVID-19: management of Cushing’s syndrome. European Journal of Endocrinology . 2020;183(1):G1–G7. doi: 10.1530/EJE-20-0352.
-
DOI
-
PMC
-
PubMed
Guarnotta V., Ferrigno R., Martino M., et al. Glucocorticoid excess and COVID-19 disease. Reviews in Endocrine & Metabolic Disorders . 2020;22(4):703–714. doi: 10.1007/s11154-020-09598-x.
-
DOI
-
PMC
-
PubMed
Pivonello R., De Leo M., Cozzolino A., Colao A. The treatment of Cushing’s disease. Endocrine Reviews . 2015;36(4):385–486. doi: 10.1210/er.2013-1048.
-
DOI
-
PMC
-
PubMed